ライフサイエンスコーパス: nodularity

1 d independently reviewed for hepatic surface nodularity.

2 eedle biopsy if required to evaluate thyroid nodularity.

3 ith 13 (34%) of these patients having antral nodularity.

4 s between PNPLA3 rs2281135 variant and tumor nodularity.

5 (SN), lobar redistribution, and hepatic vein nodularity.

6 th International Labour Office (ILO) grade 3 nodularity, 112 patients with less severe silicosis (ILO

7 ging included multiloculation (56.9%), mural nodularity (16.5%), and biliary ductal dilatation (17.7%

8 more commonly observed in malignant lesions (nodularity: 42.9% vs 10.0%; difference, 32.9%; OR, 6.72;

9 ial (RPE) atrophy (43%), RPE loss (14%), RPE nodularity (8%), photoreceptor loss (43%), inner segment

10 Multivariate analysis demonstrated mural nodularity and atypical cytopathology were predictive of

11 In this cohort study, nodularity and mass effect were associated with lesions

12 inimize the psychosocial impact and diminish nodularity and potentially tissue hypertrophy.

13 spectively scored qualitative (reticulation, nodularity, and total scores) and quantitative (contrast

14 Medulloblastomas with extensive nodularity are cerebellar tumors characterized by two di

15 patients (43%) demonstrated hepatic surface nodularity at pretransplant imaging, none of whom had ci

16 Enlarged gastric folds and antral nodularity can predict H. pylori infection with 100% PPV

17 Enlarged gastric folds and antral nodularity could be reliable predictors for H. pylori in

18 oved with the addition of a ML parameter for nodularity, Enhanced Liver Fibrosis, platelets, aspartat

19 ividuals with medulloblastoma with extensive nodularity, four of 20 with desmoplastic/nodular medullo

20 Nodularity, friability, and mass effect were more common

21 liver surface, patients with hepatic surface nodularity had a significantly greater proportion with t

22 t, some PNPLA3 variants correlate with tumor nodularity, higher miR-122 expression, and distinct demo

23 doscopy revealed gastritis with erosions and nodularity in the gastric cardia and antrum.

24 Hepatic surface nodularity is commonly seen at imaging in fulminant hepa

25 , mucus plug (k = 0.68), and solid scattered nodularity (k = 0.82).

26 s, including quantification of liver surface nodularity (LSN) for PSVD diagnosis has not been establi

27 quantitative method to measure liver surface nodularity (LSN) from routine computed tomographic (CT)

28 o determine whether use of the liver surface nodularity (LSN) score, a quantitative biomarker derived

29 toma (ND) and medulloblastoma with extensive nodularity (MBEN) have been associated with a more favor

30 toma (DMB) or medulloblastoma with extensive nodularity (MBEN; n = 42) had 93% progression-free survi

31 these cells to a nonproliferating extensive nodularity morphology.

32 ral valve) manifested predominantly (74%) as nodularities of the aortic cusps and basal thickening of

33 ents with lung cancer, smooth enlargement or nodularity of the adrenal glands at baseline CT is not a

34 5.36; 95% confidence interval, 1.84-15.56), nodularity on endoscopy (relative risk, 3.98; 95% confid

35 uct IPMN and for branch-duct IPMN with mural nodularity or positive cytology irrespective of location

36 r developed irregular wall thickening, mural nodularity, or septations that would raise concern for m

37 None developed mural irregularity, nodularity, or septations.

38 scopic abnormalities, that is, ulceration or nodularity (P = 0.0002; relative risk [RR] = 7.6; 95% co

39 e, location, septation, calcification, mural nodularity, pancreatic duct involvement, and presence of

40 (smooth or nodular septal lines, subpleural nodularity, peribronchovascular thickening, satellite no

41 llars (r = -0.73, P < .0001), and endoscopic nodularity (r = -0.45, P < .0001).

42 , and liver ultrasound parameters of surface nodularity (SN), lobar redistribution, and hepatic vein

43 ch SNP with tumor prognostic factors such as nodularity, tumor size and AFP (alpha-feto protein) leve

44 escription of landmarks and visible lesions (nodularity, ulceration) when present.

45 Nodularity was located in the gastric antrum (n = 2), bo

46 Repeat biopsy of the gastric cardial nodularity was reported as active chronic gastritis and

47 tribution, size, number, cytology, and mural nodularity were correlated with IPMN pathology.

48 iation between pleural thickness and pleural nodularity with histopathological examination findings w

49 ated tumors; 14 (93%) appeared as peripheral nodularity with low-grade enhancement.